A China-based pharmaceutical company is seeking candidate companies for M&A purpose. With over 2,000 employees, this Chinese company is well-established in the China market and has over 3,000 hospitals as its end-customers. It is interested in target companies that produce pharmaceuticals in the following areas: orthopaedics, oncology, cardiovascular, gastroenterology, neurology, hepatology, and gynaecology. It will also want to consider companies that possess advanced technologies in Sustained Release Microsphere Depot Systems or liposome Drug Delivery Systems. The latest annual revenue of the candidate should not exceed approximately US$ 100 million, and its key products should have passed regulatory certifications in its main markets. Private companies will be preferred over public companies as candidates. The Chinese company will prefer to acquire a majority stake, and may settle as a minority shareholder in case of very attractive candidates.
If you are a potential candidate company, contact us today.
